Active substances
Dermatophagoides farinae + Dermatophagoides pteronyssinus
- Health Canada 4
- UK MHRA 4
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACARIZAX | 02463644 | 6 UNIT; 6 UNIT | TABLET · SUBLINGUAL | ALK-ABELLÓ A/S |
| ALLERGENIC EXTRACT - STANDARDIZED MITE MIX | 02231325 | 5000 UNIT / ML; 5000 UNIT / ML | LIQUID · SUBCUTANEOUS; INTRACUTANEOUS | GREER LABORATORIES INC |
| ALLERGENIC EXTRACT MIXTURE OF STANDARDIZED MITES (5,000 AU/ML) | 02223996 | 5000 UNIT / ML; 5000 UNIT / ML | SOLUTION · PERCUTANEOUS; SUBCUTANEOUS | JUBILANT HOLLISTERSTIER LLC |
| ALLERGENIC EXTRACT, STANDARDIZED MITE MIXED | 02270919 | 5000 UNIT / ML; 5000 UNIT / ML | LIQUID · INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS | ALK-ABELLO INC |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| ACARIZAX 12 SQ-HDM ORAL LYOPHILISATE | PL 10085/0058 | ALK ABELLO A-S | POM |
| ACTAIR 100 IR & 300 IR SUBLINGUAL TABLETS | PL 04534/0014 | STALLERGENES | POM |
| ACTAIR 100 IR SUBLINGUAL TABLETS | PL 04534/0013 | STALLERGENES | POM |
| ACTAIR 300 IR SUBLINGUAL TABLETS | PL 04534/0015 | STALLERGENES | POM |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.